There is still no definitive evidence that microdosing with psychedelics is either effective or safe. Keep reading to read the potential benefits and risks.
Read moreHave You Heard of Jurema?
DMT has been extracted from the jurema-preta (black jurema) tree (Mimosa tenuiflora), which is widely found in the dry Caatinga Region of Northeastern Brazil.
It is being researched in Brazil for potential in helping those with depression.
Read moreLSD, Anxiety and Depression
New research finds LSD effective in decreasing anxiety and depression.
Researchers report “effects were maximal 2 weeks after the second LSD session and sustained up to 16 weeks.”
Read morePsychedelics: Decriminalization vs. Legalization
What’s the difference between decriminalization and legalization of psychedelics? Keep reading!
Read morePsychedelics- Today vs. 1960s
Here’s an interesting look at the history of psychedelics and some trends.
Read morePsychedelics for Fear of Death
According to a new survey conducted by researchers at Johns Hopkins Medicine, published Aug. 24 in the journal PLOS ONE, people’s attitudes about death change after both a psychedelic drug experience and a non-drug-related out-of-body experience.
People were less afraid of death than they had been before their experiences.
Read moreMicrodosing- Panacea or Placebo?
Is it all hype or is there genuine hope for therapeutic application of microdosing?
There’s certainly plenty of ‘conflicting’ information or results available from studies of different methodologies. Here, we begin with an overview of what microdosing is, who does it, and for what purposes. We then review available evidence and summarize benefits and risks of microdosing. Finally, we get more practical and discuss microdosing regimens, measurement of accurate dosing, and ‘set and setting’ consideration to microdosing.
from Ben Malcolm, Spirit Pharmacist
Psilocybin for Alcohol Addiction
In a study published Wednesday in JAMA Psychiatry, scientists found that patients taking this drug, called psilocybin, had an 83 percent decline in heavy drinking, while those who took a placebo experienced a 51 percent decline.
Read morePsychedelics for Depression
Here’s the latest on how psychedelics may help treat depression.
Read morePsilocybin for Late-Stage Cancer
CU Cancer Center researchers are collaborating on NCI-funded research to understand the effects of psilocybin on the depression and anxiety that people with cancer can feel.
Read moreIboga for PTSD for Vets
Veterans are turning to psychedelic treatments for PTSD healing.
Read more